This aligns with a retrospective cohort study that showed that insulin requirements did not differ between COVID-19 patients and non-COVID viral pneumonitis patients, which argues against the theory that SARS-CoV-2 attacks the pancreas [15]. This evidence concerns the gene INS and COVID-19.